M. Lindholm et A. Eklund, INHIBITORY EFFECT OF GASTRIN AND CHOLECYSTOKININ FRAGMENTS ON THE SECRETION OF TRIACYLGLYCEROL IN RAT HEPATOCYTES, Hepatology, 18(5), 1993, pp. 1232-1237
In this investigation we studied the influence of two gastrin fragment
s, pentagastrin and nonsulfated heptadecagastrin, and two cholecystoki
nin fragments, sulfated and desulfated cholecystokinin 26-33, on intra
cellular and secreted triacylglycerol in isolated hepatocyte cultures.
Both gastrin fragments inhibited triacylglycerol release in a biphasi
c manner, exhibiting maximal effect at 0.1 nmol/L (nonsulfated heptade
cagastrin) and 0.3 nmol/L (pentagastrin). At these concentrations tria
cylglycerol secretion was 42% (non-sulfated heptadecagastrin, p < 0.00
1) and 62% (pentagastrin, p < 0.001) lower than in cells untreated wit
h gastrin. Sulfated cholecystokinin 26-33 caused a 35% decrease in tri
acylglycerol secretion at 0.1 nmol/L (p < 0.01), and desulfated cholec
ystokinin 26-33 caused a 53% decrease at 0.2 nmol/L (p < 0.001). In al
l experiments, the hormone-induced decrease in triacylglycerol secreti
on was accompanied by an increase in intracellular triacylglycerol con
tent. The cholecystokinin-A receptor antagonist L-364, 718 did not aff
ect the decrease in triacylglycerol secretion induced by 0.3 nmol/L pe
ntagastrin, whereas the cholecystokinin-B receptor antagonist L-365, 2
60 inhibited the pentagastrin effect at concentrations above 50 nmol/L
. These results suggest that gastrin, cholecystokinin or some other ga
strinlike hormone (or all three) may play a previously unrecognized re
gulatory role with respect to hepatic very low density lipoprotein sec
retion.